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Abstract
AIM: To identify novel substrates for the mitogen-acti-
vated protein kinase-activated protein kinase 5 (MK5). 
METHODS: Yeast two-hybrid screening with MK5 as 
bait was used to identify novel possible interaction part-
ners. The binding of putative partner was further ex-
amined by glutathione S-transferase (GST) pull-down, 
co-immunoprecipitation and fluorescence resonance 
energy transfer (FRET) analysis. In vitro  kinase and 
peptide array assays were used to map MK5 phospho-
acceptor sites on the new partner. Confocal microscopy 
was performed to study the subcellular localization of 
MK5 and its partners.
RESULTS: Septin 8 was identified as a novel interac-
tion partner for MK5 by yeast two-hybrid screening. 
This interaction was confirmed by GST pull-down, co-
immunoprecipitation and FRET analysis. Septin 5, which 
can form a complex with septin 8, did not interact with 
MK5. Serine residues 242 and 271 on septin 8 were 
identified as in vitro  MK5 phosphorylation sites. MK5 
and septin 8 co-localized in the perinuclear area and in 
cell protrusions. Moreover, both proteins co-localized 
with vesicle marker synaptophysin.
CONCLUSION: Septin 8 is a bona fide interaction 
partner and in vitro  substrate for MK5. This interaction 
may be implicated in vesicle trafficking.
© 2012 Baishideng. All rights reserved.
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INTRODUCTION
The group of  mitogen-activated protein kinases (MAPKs) 
participates in control of  several vital processes, includ-
ing metabolism, transcription, apoptosis, cell cycle pro-
gression, differentiation, cytoskeletal rearrangement and 
cell movement. MAPK-activated protein kinase 5 (MK5), 
also designated PRAK, belongs to the group of  kinases 
downstream of  MAPK, originally identified as in vitro p38 
MAPK substrate[1,2]. Biological functions of  MK5 are 
poorly understood despite the high similarity in structure 
with other widely studied members of  the subgroup[3]. 
Recent studies have highlighted the importance of  MK5 
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in ras-induced senescence, antiproliferation, tumor sup-
pression, anxiety-related behavior, energy-depletion-
induced suppression of  mammalian target of  rapamycin 
C1, rearrangements of  the cytoskeleton, endothelial cell 
migration, and tumor angiogenesis[4-9]. Several bona fide 
substrates have been identified, including extracellular 
signal-regulated kinase (ERK)3, ERK4, 14-3-3ε, p53, Ras 
homolog enriched in brain (Rheb) and heat shock protein 
(Hsp)27[6,8,10-15]. The role of  MK5 in actin architecture 
involves its link with 14-3-3ε and Hsp27[14,15], while MK5-
mediated phosphorylation of  p53 at Ser-37 results in 
increased transcription of  p21Cip1, and inhibition of  cell 
proliferation[6,16]. The biological relevance of  MK5-ERK3 
and MK5-ERK4 interactions remains unknown.
Septins belong to a group of  small GTPases that were 
originally described in the budding yeast Saccharomyces 
cerevisiae as a group of  cell division cycle regulatory genes. 
Proteins were isolated in yeast through the analysis of  
temperature-sensitive mutants showing impaired cytokine-
sis and budding[17]. Their role in formation of  the septum 
between mother and daughter yeast cells is the back-
ground for the given name septins[17,18]. Septins are highly 
conserved and have been identified in most cell types of  
multicellular organisms[19]. Fourteen septin genes (SEPT1-
SEPT14) have been characterized to date in humans[20]. 
Septin genes undergo alternative splicing and produce 
multiple protein products that are expressed at different 
ratios in different tissues[20]. These GTP-binding proteins 
are involved in diverse processes such as cytokinesis, 
membrane remodeling and compartmentalization, cyto-
skeleton rearrangement, vesicle trafficking, and apopto-
sis[18,20,21]. Knockout mice have been generated for SEPT3, 
4, 5, 6, 7 and 9 genes[22]. SEPT7-/- and SEPT9-/- mice were 
embryonic lethal, while SEPT3-/- and SEPT6-/- mice had 
no obvious phenotype[23,24]. SEPT4-/- mice had defects in 
behavior and reproduction, while SEPT5-/- animals had 
elevated platelet hypersensitivity[25-27]. Septins have been 
reported to be perturbed in various human diseases, in-
cluding neurological disorders, infection, and neoplasia[28]. 
SEPT8 was first identified as an interaction partner 
for SEPT5 by yeast two-hybrid screening[29], and is an 
alternatively spliced septin with 14 known transcripts and 
10 different isoforms that are expressed in a variety of  
human tissues[20]. SEPT-SEPT interaction studies using 
yeast two- and three-hybrid assays revealed heterodimeric 
SEPT2:SEPT8, SEPT3:SEPT8, SEPT4:SEPT8, SEPT7:
SEPT8 and SEPT9:SEPT8 complexes and heterotrimeric 
SEPT2:SEPT8:SEPT7, SEPT4:SEPT8:SEPT7, SEPT5:
SEPT8:SEPT7, SEPT2:SEPT8:SEPT9, SEPT4:SEPT8:
SEPT9, SEPT5:SEPT8:SEPT9 complexes[30]. SEPT8 
together with SEPT4 and SEPT5 have been designated 
platelet septins due to high expression and interaction in 
these cells. Moreover all three septins are highly expressed 
in brain and heart tissues as well as in prostate, testis and 
ovary[31]. In platelets, they have marked preference for ar-
eas surrounding α-granules. Activation of  platelets leads 
to translocation of  SEPT4 and SEPT8 to the platelet 
surface[32]. SEPT5 is involved in exocytosis (serotonin 
release) in platelets and may regulate synaptic vesicle 
dynamics[25,33-35]. SEPT8 is expressed in rat brain and ex-
pression is developmentally regulated[36]. Besides septin 
proteins, other proteins have been shown to interact with 
SEPT8. Vesicle-associated membrane protein (VAMP)2 
and syntaxin1A have been identified as binding partners 
for SEPT8. Furthermore, SEPT8 in rat brain disrupts the 
binding of  VAMP2 to synaptophysin. These results sug-
gest a possible involvement of  SEPT8 in the regulation 
of  soluble N-ethylmaleimide-sensitive factor attachment 
protein receptor (SNARE) complex formation and sub-
sequent exocytosis[36], but experimental proof  is lacking 
and the biological role of  SEPT8 remains unknown.
To increase the understanding of  biological functions 
of  MK5, we used the yeast two-hybrid system and identi-
fied SEPT8 as a new interaction partner. SEPT8 appears 
to be phosphorylated by MK5 in vitro. These two proteins 
showed co-localization in the perinuclear area or protru-
sions of  the cells as well as co-localization with synapto-
physin in a neuroblastoma cell line. These results support 
previous assumptions on the role of  SEPT8 in exocytosis 
and may indicate a possible involvement of  MK5 in regu-
lated secretion through phosphorylation of  SEPT8. 
MATERIALS AND METHODS
Yeast two-hybrid screening
Yeast two-hybrid screening of  MK5 was performed in 
yeast PBN204 strain containing three reporters (URA3, 
lacZ, and ADE2) that are under the control of  different 
GAL promoters. Yeast transformants of  the MK5 bait 
and human brain cDNA AD library were spread on selec-
tion medium (SD-leucine, tryptophan, uracil; SD-LWU) 
that supports growth of  yeast with bait and prey plasmids 
yielding proteins interacting with each other. 
Antibodies
The anti-PRAK (A7) and anti-SEPT8 antibodies were 
from Santa Cruz Biotechnology (Santa Cruz, CA, United 
States). Anti-synaptophysin fluorescein isothiocyanate 
(FITC) conjugate (SY38) antibodies were purchased from 
Progen Biotechnik GmbH (Heidelberg, Germany). The 
alkaline-phosphatase-conjugated secondary antibodies 
sheep anti-mouse IgG and anti-rabbit IgG were from 
Sigma Aldrich (St. Louis, MO, United States).
Plasmid construction and mutagenesis
The plasmid pRK5-flag-Sept8 was a kind gift from Dr. 
Koh-Ichi Nagata and Dr. Masaki Inagaki (Aichi Cancer 
Center Research Institute, Nagoya, Japan)[37]. pGEX-
Sept8 and AsRed-Sept8 plasmids were generated by di-
gesting pRK5-flag-Sept8 with EcoRI and XhoI or BspEI 
and XhoI, respectively, and ligation into corresponding 
vectors, namely pGEX-4T-1 (GE Healthcare, Oslo, 
Norway) and AsRed-C1 (BD Biosciences, Trondheim, 
Norway). All plasmids were verified by sequencing. The 
MK5 expression plasmid has been previously described[38]. 
The oligonucleotides 5'-GCAGTCGACATGGCGGC-
CACCGACCTGGA-3' and 5'-TATGCGGCCGCT-
TAATTCTTCTTGTCCTTG-3' were used to amplify 
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SEPT8-fragment from pRK5-Flag-Sept8. Then, the 
fragment of  SEPT8 was cut with SalI/NotI and ligated 
into the corresponding sites of  pENTR1A (Invitrogen, 
Dynal AS, Oslo, Norway). The pEGFP-MK5 was di-
gested with SmaI/EcoRI, and the fragment ligated into the 
corresponding sites of  pBluescript SK plus. The resulting 
pBluescript-MK5 construct was then digested with Eco-
RI/NotI, and the fragment ligated into the corresponding 
sites of  pENTR2B (Invitrogen). The pcDNA-CREB 
(cAMP response element-binding protein) plasmid was 
digested with KpnI/NotI, and the fragment ligated into 
the corresponding sites of  pENTR3C (Invitrogen). The 
resulting pENTR-SEPT8, pENTR-MK5 and pENTR-
CREB clones were further recombined with Gateway 
destination vectors pDest-EYFP and pDest-ECFP (a gift 
from Dr. Terje Johansen, University of  Tromso, Norway) 
generating EYFP-SEPT8, ECFP-SEPT8, EYFP-MK5, 
ECFP-MK5, EYFP-CREB and ECFP-CREB.
Glutathione S-transferase-fusion protein purification
Glutathione S-transferase (GST) fusion proteins were puri-
fied from Escherichia coli (E. coli) BL21 extracts using glutathi-
one-agarose beads as previously described[38], and the GST 
moiety was removed from the GST beads by use of  throm-
bin according to the instructions of  the manufacturer.
In vitro kinase assays
Peptide arrays were synthesized on cellulose paper by using 
MultiPep automated multiple peptide synthesizer (INTA-
VIS Bioanalytical Instruments, Koln, Germany). Successive 
20-mer peptides spanning the complete SEPT8 protein 
were synthesized. Each consecutive peptide had a three-
amino-acid shift compared to the previous peptide. For 
phosphorylation, membranes were briefly wet in ethanol 
prior to incubation in phosphorylation buffer [20 mmol/L 
HEPES, pH 7.4, 100 mmol/L NaCl, 5 mmol/L MgCl2, 
1 mmol/L dithiothreitol (DTT), and 0.2 mg/mL bovine 
serum albumin (BSA)] for 1 h at room temperature. There-
after, the array was incubated at 4 ℃ overnight in blocking 
buffer (phosphorylation buffer containing 1 mg/mL BSA 
and 100 μmol/L ATP). Phosphorylation was initiated by 
incubating the membrane in the presence of  activated MK5 
(Millipore Upstate, Billerica, MA, United States) in 20 mL 
phosphorylation buffer containing 50 μmol/L ATP and 
0.37 MBq of  [γ-32P] ATP for 30 min at 30 ℃ with agita-
tion. The membrane was washed extensively in 1 mol/L 
NaCl followed by washes in 5% H3PO4 and dried down[39]. 
The phosphorylated membrane was then visualized by 
the FUJIFILM BioImaging Analyser (type BAS-5000). In 
vitro phosphorylation of  SEPT8 by activated MK5 was 
performed in 25 mmol/L Tris-HCl, pH 7.5, 10 mmol/L 
MgCl2, 0.05 mg/mL BSA, 2.5 mmol/L DTT, 0.15 mmol/L 
cold ATP, and 0.3 μL [γ-32P] ATP (3000 Ci/mmol; GE 
Healthcare) in a total volume of  40 μL at 30 ℃ for 1 h. The 
reaction was stopped in 4 × lithium dodecyl sulfate (LDS) 
Sample buffer, and proteins were denatured at 70 ℃ for 
10 min. The phosphorylation was analyzed on NuPAGE 
4%-12% BisTris SDS-PAGE (Invitrogen) for 50 min at 200 
V and then subjected to autoradiography.
Cell culture and transfections
The human neuroblastoma cell line SK-N-DZ (CRL-2194) 
was from ATCC (LGC Promochem, Middlesex, United 
Kingdom), while PC12 cells were purchased from the 
European Collection of  Cell Culture (ECACC; Wiltshire, 
United Kingdom). The cells were maintained in RPMI 
1640, supplemented with 10% horse serum (Gibco) and 
5% fetal bovine serum, 2 mmol/L L-glutamine, penicillin 
(110 U/mL) and streptomycin (100 μg/mL). Cells were 
transfected using the Nucleofection kit (Amaxa) according 
to the manufacturer’s instructions. HEK293 cells (ATCC 
CRL-1573) and HeLa cells (ATCC CCL-2) were purchased 
from the American Type Culture Collection (LGC Stan-
dards, Boras, Sweden) and maintained in Eagle’s minimum 
essential medium supplemented with 10% fetal calf  serum 
(Invitrogen Life Technologies, Carlsbad, CA, United States), 
2 mmol/L L-glutamine, (110 U/mL) and streptomycin (100 
μg/mL). HeLa cells also received 1 × nonessential amino 
acids (Invitrogen). HeLa cells were transfected with Lipo-
fectamine 2000 (Invitrogen). 
Co-immunoprecipitation
HEK293 cell extracts were harvested and lysed in buf-
fer containing 20 mmol/L Tris-HCl, pH 7.5, 1% Triton 
X-100, 5 mmol/L sodium pyrophosphate, 50 mmol/L 
sodium fluoride, 1 mmol/L EDTA, 1 mmol/L EGTA, 
1 mmol/L sodium orthovanadate, 0.27 mol/L sucrose, 
10 mmol/L β-glycerophosphate, and complete protease 
inhibitor cocktail (Roche Applied Sciences, Oslo, Norway). 
Lysates were cleared by centrifugation at 4 ℃ for 10 min 
at 15 000 g. Lysates were incubated with the appropriate 
antibody for at least 1 h at 4 ℃, before addition of  60 μL 
slurry [i.e., 30 μL protein G-agarose (GE Healthcare) 
equilibrated with 30 μL lysis buffer] and incubated for an 
additional 1 h. The immunoprecipitates were then washed 
three times in lysis buffer and twice in 50 mmol/L Tris-
HCl, pH 8.0. Twenty microliters of  2 × LDS sample buf-
fer were added to the beads before denaturation at 70 ℃ 
for 10 min. The immunoprecipitates were analyzed on 
western blotting. 
Fluorescent microscopy and fluorescence resonance 
energy transfer 
Cells with ectopically expressed proteins fused with 
green fluorescent protein or red fluorescent proteins 
were analyzed directly using confocal laser scanning mi-
croscope (LSM 510 META; Zeiss, Oslo, Norway). For 
fluorescence resonance energy transfer (FRET) analysis, 
HeLa cells were cotransfected with ECFP-MK5 and EY-
FP-SEPT8 or EYFP-CREB using TransIT-LT1 trans-
fection reagent (Mirus Bio LLC, Madison, WI, United 
States). Then, 24 h after transfection, the cells were fixed 
with 4% formaldehyde. FRET analysis was carried out 
with a Leica TCS SP5 confocal microscope with a × 63, 
1.2 W objective. Cyan fluorescent protein (CFP) and yel-
low fluorescent protein (YFP) were excited with separate 
laser channels of  458 and 514 nm, respectively. Emission 
fluorescence intensity data was obtained at 465-500 nm 
(CFP) and 525-600 nm (YFP). CFP and YFP emission 
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signals were captured before and after 50% photobleach-
ing YFP. FRET is indicated as the relative increase in 
CFP emission following YFP photobleaching. The imag-
ing system was controlled by the Leica Application Suite 
Advanced Fluorescence software (http://www.leicami-
crosystems.com).
Western blotting
For detection of  coimmunoprecipitates and SEPT8, sam-
ples were analyzed by SDS-PAGE on NuPAGE 4%-12% 
BisTris SDS-PAGE gels from Invitrogen according to 
the manufacturer’s protocol and blotted onto a 0.45-μm 
polyvinylidene difluoride membrane (Millipore). Im-
munoblotting was performed by first blocking the mem-
brane with phosphate buffered solution (PBS)-T [PBS 
with 0.1% Tween 20 (Sigma) containing 10% (w/v) dried 
skimmed milk for 1 h and probed either by anti-PRAK 
or anti-SEPT8]. After three washes, the membrane was 
incubated with the appropriate secondary antibody for 1 h. 
Visualization of  proteins was achieved by using CDP Star 
substrate (Tropix, Bedford, MA, United States) and Lumi-
Imager F1 from Roche Applied Sciences. MagicMark™ 
western standard was from Invitrogen Life Technologies. 
GST pull down
Cell lysate was precleared with 25 mg GST and 50 mL 
50% slurry of  glutathione-agarose beads for 2 h at 4 ℃. 
An input control was taken, and the cell lysate was divid-
ed into two tubes and 10 mg GST or GST-SEPT8 were 
added. The GST proteins were recovered after addition 
of  glutathione beads and washed extensively in PBS-T. 
The proteins were eluted from the beads by addition of  
20 mL loading buffer (LDS-buffer with 100 mmol/L 
DTT) followed by 10 min incubation at 70 ℃. The GST 
proteins were subsequently subjected to immunoblot 
analysis.
Densitometry
Densitometry was performed using a BioRad Model 
GS-700 Imaging Densitometer (Oslo, Norway) and the 
Multi-Analyst version 1.1 Software.
RESULTS
Screening of proteins that interact with MK5
To elaborate the biological functions of  MK5, we decided 
to identify novel substrates for MK5. A yeast two-hybrid 
screen with MK5 as bait and a brain cDNA library was 
designed. After selecting yeast colonies on uracil-deficient 
medium, the activity of  β-galactosidase was monitored. 
The URA+ and lacZ+ colonies were also tested for wheth-
er they could grow on adenosine-deficient medium. To 
maximize the specificity of  the screening, protein-protein 
interaction was tested using three independent reporters 
with different types of  GAL4-binding sites. This proce-
dure eliminates interactions that result from nonspecific 
promoter activation. In order to confirm the interaction, 
the prey plasmids from 29 candidates that expressed at 
least two reporters were selected by E. coli transformation, 
and then the candidate prey plasmids were reintroduced 
into yeast with MK5 bait plasmid or with a negative con-
trol plasmid expressing GAL4-binding domain but lack-
ing the bait part. Twenty real positives were identified that 
encoded three different proteins. Among 20 real positives, 
17 preys contained the same cDNA encoding SEPT8_v2 
(AF440762). Two other positive clones encoded the previ-
ously reported MK5 interaction partner ERK3[10,11].
SEPT8 binds to MK5 in vitro and in vivo
To verify the interaction observed in the yeast two-hybrid 
system, GST pull-down was performed. Lysates of  
HEK293 cells transfected with the expression plasmid for 
GFP-MK5 were incubated with glutathione-sepharose 
beads accompanied by either GST alone or GST-SEPT8. 
After immunoprecipitation, MK5 was detected by western 
blotting using anti-PRAK antibody. The results showed 
that MK5 could bind GST-SEPT8 (Figure 1A) but not 
GST alone.
To establish whether complexes of  MK5 and SEPT8 
existed within mammalian cells, HEK293 cells were co-
transfected with MK5 and SEPT8 expression plasmids 
because these cells give high transfection efficiency. Re-
ciprocal coimmunoprecipitation studies were conducted 
with anti-PRAK antibody followed by western blotting 
with anti-SEPT8 antibody, or immunoprecipitation with 
anti-SEPT8 antibody followed by western blotting with 
anti-PRAK antibody. Specific interaction was monitored 
between the two proteins (Figure 1B and C). The signal 
in the last lane in Figure 1C (lysate of  cells expressing 
ectopically expressed SEPT8 but not MK5) was due to 
interaction of  SEPT8 with endogenous MK5. No inter-
actions were visualized in the control precipitation using 
vehicles. To detect interaction between endogenous MK5 
and SEPT8, PC12 cells were used because both MK5 and 
SEPT8 are relatively highly expressed in neural cells[1,2,36]. 
MK5 could be detected when endogenous SEPT8 was 
immunoprecipitated (Figure 1D). Combined, our results 
clearly demonstrate that MK5 and SEPT8 specifically 
interact in vitro and in vivo. SEPT8 was originally identi-
fied as an interaction partner for SEPT5[29], therefore, we 
tested whether MK5 and SEPT5 complexes were found 
in cells. Coimmunprecipitation studies failed to detect 
MK5:SEPT5 complexes (results not shown).
We performed FRET analysis to monitor interaction 
between MK5 and SEPT8 in cells. HeLa cells were trans-
fected with expression plasmids for MK5 and SEPT8. 
As a negative control, we included CREB because it does 
not interact with MK5[4]. After photobleaching, interac-
tion between MK5 and SEPT, but not MK5 and CREB, 
was observed as indicated by a relative increase in CFP 
emission following YFP photobleaching (Figure 2).
MK5 phosphorylates SEPT8 in vitro
In previous studies, several septins have been shown 
to be phosphorylated in vitro and/or in vivo, including 
SEPT1, SEPT2, SEPT3 and SEPT5[40-44]. After describ-
ing the interaction between two proteins, we wanted to 
know whether MK5 possesses catalytic activity towards 
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SEPT8. To test this, GST-SEPT8 fusion protein was puri-
fied from bacteria and the GST moiety was enzymatically 
cleaved. SEPT8 was then incubated with commercially 
available active MK5 in an in vitro kinase assay. Phospho-
proteins were fractionated by SDS-PAGE on a 4%-20% 
acrylamide gradient gel and visualized by autoradiography. 
As shown in Figure 3A, SEPT8 was phosphorylated by 
MK5. As previously reported, MK5 autophosphorylation 
activity of  MK5 was observed[38]. An additional band, 
corresponding to phosphorylated SEPT8 was detected. 
These results demonstrate that MK5 can phosphorylate 
of  SEPT8 in vitro.
Identification of phosphorylation sites on SEPT8
To identify MK5 phosphoacceptor sites on SEPT8, we 
performed an in vitro kinase assay using peptide arrays. One 
separate peptide, YFIT237PT239GHS242LKS245LDLVT250MK
K and two consecutive peptides IPIIAKADT269IS271KS273 
ELHKFKI and IAKADT269IS271KS273ELHKFKIKIM 
appeared phosphorylated (Figure 3B). Putative phospho-
acceptor sites for the serine/threonine MK5 kinase are 
marked. We analyzed the SEPT8 sequence with NetPhos 
2.0 (accessible on the internet: http://www.cbs.dtu.dk/
services/NetPhos/). This software algorithm predicts the 
potential phosphorylation sites in proteins. According to 
the NetPhos description, scores close to 1 are the most 
likely to represent an actual phosphorylation site. Among 
all predicted sites, two serine residues in the sequences of  
peptides that were phosphorylated on peptide array had a 
high score, namely 0.994 for Ser-242 and 0.944 for Ser-271. 
We generated plasmids encoding GST-SEPTS242A, GST-
SEPTS271A and GST-SEPTS242A/S271A in which 
these Ser residues were replaced by alanine and expressed 
these fusion proteins in bacteria. GST was enzymatically 
removed from the purified proteins and in vitro kinase assay 
with active MK5 was performed. Mutation of  Ser-242 or 
Ser-271 into Ala reduced MK5-mediated phosphorylation 
of  SEPT8, but the former substitution had less effect than 
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Figure 1  Mitogen-activated protein kinase-activated protein kinase 5 and SEPT8 interact in vitro and in vivo. A: Glutathione S-transferase (GST) pull-down 
assay. GST-SEPT8 or GST alone purified from Escherichia coli and immobilized on glutathione-Sepharose beads were incubated for 60 min with lysate of HEK293 
cells transfected with GFP-mitogen-activated protein kinase-activated protein kinase 5 (MK5). After washing the beads five times, bound proteins were eluted by 
boiling, subjected to SDS-PAGE, and immunoblotted with anti-PRAK (upper panel) or anti-SEPT8 (lower panel) antibody. Lane 1: Protein molecular mass marker (in 
kDa); lane 2: Cell lysate; lane 3: Cell lysate after pull down with GST; lane 4: Cell lysate after pull down with GST-SEPT8; B: Coimmunoprecipitation of FLAG-SEPT8 
and hemagglutinin (HA)-MK5. HA-MK5- and/or FLAG-SEPT8-encoding plasmids were transiently expressed in HEK293 cells. Total cellular lysates (input; lanes 1-3) 
and SEPT8 immunoprecipitates (IP: α-SEPT8; lanes 4-6) were probed with anti-PRAK (upper panel) and anti-SEPT8 (lower panel) antibody. Lane 1: Cell lysate of 
cells cotransfected with expression plasmids for HA-tagged MK5 and FLAG-tagged SEPT8; lane 2: Cell lysate of cells cotransfected with expression plasmids for HA-
tagged MK5 and empty vector for SEPT8; lane 3: Cell lysate of cells cotransfected with expression plasmids for FLAG-tagged SEPT8 and empty vector for MK5; lane 
4: Immunoprecipitated lysate of cells cotransfected with expression plasmids for HA-tagged MK5 and FLAG-tagged SEPT8; lane 5: Immunoprecipitated lysate of cells 
cotransfected with expression plasmids for HA-tagged MK5 and empty vector for SEPT8; lane 6: Immunoprecipitated lysate of cells cotransfected with expression 
plasmids for FLAG-tagged SEPT8 and empty vector for MK5; C: Coimmunoprecipitation of HA-MK5 and FLAG-SEPT8. HEK293 cells were transiently transfected 
with expression plasmids for HA-MK5 and/or FLAG-SEPT8. Total cellular lysates (input) and HA-MK5 immunoprecipitates (IP: α-MK5) were probed with anti-SEPT8 
(upper panel) and anti-PRAK (lower panel) antibody. Lanes 1-3: Lysates from transfected cells; lanes 4-6: Immunoprecipitation of cell lysates. See (B) for details; D: 
Coimmunoprecipitation of endogenous MK5 and SEPT8. Endogenous SEPT8 was immunoprecipitated from PC12 cells with anti-SEPT8 antibodies and the precipi-
tate was analyzed for the presence of MK5 by anti-PRAK antibodies. Lane 1: Protein molecular mass marker (in kDa); lane 2: Lysate of PC12 cells (= input); lane 3: 
Immunoprecipitation with SEPT8 antibodies. The bottom panel shows control western blot with SEPT8 antibodies. IP: Immunoprecipitation; WB: Western blotting.
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Figure 2  Fluorescence resonance energy transfer analysis shows interaction between mitogen-activated protein kinase-activated protein kinase 5 and 
SEPT8. (A) HeLa cells were cotransfected with expression plasmids for heat shock protein (CFP)-tagged mitogen-activated protein kinase-activated protein kinase 5 
(MK5) and yellow fluorescent protein (YFP)-tagged CREB or (B) with expression vectors for CFP-tagged MK5 and YFP-tagged SEPT8. Twenty-four hours after trans-
fection, cells were fixed and fluorescence resonance energy transfer (FRET) analysis was carried out. CFP and YFP were excited with separate laser channels of 
458 and 514 nm, respectively. Emission fluorescence intensity data were obtained at 465-500 nm (CFP) and 525-600 nm (YFP). CFP and YFP emission signals were 
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the latter on phosphoSEPT8 levels. The double SEPT8 
S242A/S271A substitution did not further reduce the 
phosphorylation levels of  SEPT8 (Figure 3C). These find-
ings indicate that Ser-271 and to a lesser extend Ser-242 
represent in vitro targets for MK5, but that additional ami-
no acid residues can be phosphorylated by MK5 in vitro. 
MK5 colocalizes with SEPT8 in HEK293 and PC12 cells
To examine cellular localization of  MK5 with SEPT8, 
confocal microscopy was performed on HEK293 cells 
expressing GFP-MK5 and AsRed-SEPT8 fusion proteins 
separately (Figure 4A) or simultaneously (Figure 4B). As 
previously reported, GFP-MK5 protein resides predomi-
nantly in the nucleus, but can also be detected in the cy-
toplasm[38], while The RFP-SEPT8 protein is exclusively 
located in the cytoplasm (Figure 4A). Cotransfection with 
expression plasmid encoding tagged MK5 and SEPT8 
demonstrated colocalization of  these two proteins in the 
perinuclear area (Figure 4B). Several studies have shown 
the involvement of  septins in neuronal transmission and 
exocytosis. Therefore, we wanted to test if  a similar colo-
calization pattern of  proteins could be seen in neuroen-
docrine PC12 cells. Colocalization was observed not only 
in cell bodies but also in neurite terminals of  PC12 cells 
(Figure 4C). Interestingly, a previous study showed that 
SEPT5 was concentrated near the plasma membrane and 
in growth cones of  PC12 cells[45].
MK5 and SEPT8 colocalize with synaptophysin in the 
neuroblastoma cell line SK-N-DZ
In a previous study, SEPT8 colocalized with the synaptic 
marker synaptophysin[36]. To examine the cellular localiza-
tion of  SEPT8 with synaptophysin in the neuroblastoma 
cell line SK-N-DZ, cells were transfected with AsRed-
SEPT8. Protein was visualized directly, and anti-synapto-
physin FITC conjugate antibodies were used to monitor 
synaptophysin localization. SEPT8 and synaptophysin 
showed strong colocalization (Figure 5A), confirming 
the findings by Ito and colleagues[36]. We then investi-
gated whether MK5 could colocalize with synaptophysin 
because we had observed colocalization with SEPT8 in 
several cell lines. Indeed, MK5 colocalized with synapto-
physin in a similar fashion as SEPT8 (Figure 5B). 
DISCUSSION
Several genuine substrates have been identified for MK5 in-
cluding ERK3, ERK4, 14-3-3ε, p53, Rheb and Hsp27[6,8,10-15]. 
However, the functions of  MK5 remain elusive, and 
MK5-deficient mice appear normal or die at embryonic 
stage E11.5, depending on the genetic background of  the 
mice[6,10,46]. In our search for other possible MK5 interac-
tion partners that may provide a clue to the biological 
functions of  MK5, we have identified SEPT8 as an in vitro 
MK5 substrate. The interaction was originally revealed by 
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Figure 3  Mitogen-activated protein kinase-activated protein kinase 5 phosphorylates septin 8 in vitro. A: In vitro kinase assay on recombinant SEPT8. Glu-
tathione S-transferase (GST)-SEPT8 fusion protein was purified from Escherichia coli and the GST moiety was removed by thrombin. SEPT8 was incubated with 
activated mitogen-activated protein kinase-activated protein kinase 5 (MK5) for 30 min at 30 ℃ in the presence of [γ-32P] ATP. Proteins were separated by SDS-PAGE 
and phosphorylation was visualized by autoradiography (upper panel). Loading control for MK5 (middle panel) and SEPT8 (lower panel) was performed by western 
blotting with anti-PRAK and anti-SEPT8 antibodies, respectively. Lane 1: Recombinant activated MK5; lane 2: Purified SEPT8 protein; lane 3: recombinant MK5 and 
purified SEPT8; B: SEPT8 peptide array was subjected to in vitro phosphorylation by activated MK5. Each spot represents a 20-mer peptide fragment of SEPT8. The 
peptide fragments constitute the complete SEPT8 protein. The sequential peptide has a 17-amino acid overlap with the previous peptide. Several spots with peptides 
were detected by autoradiography (lower panel). Ser-242 and Ser-271 with highest prediction score 0.994 and 0.944, respectively by Netphos software, were chosen 
as possible phosphorylation sites in the peptide sequences. The upper panel represents Ponceau staining of the peptide array membrane used. The sequences of 
the peptides representing the positive spots are shown; C: In vitro phosphorylation of wild-type SEPT8, and SEPT8 mutants carrying a single amino acid substitution 
(Ser-242 into Ala or Ser-271 into Ala, respectively) or the double amino acid substitution Ser-242 and Ser-271 into Ala. The upper band represents autophosphory-
lated MK5, while the lower band is phosphorylated SEPT8. Relative densitometry units (RDU) of the bands representing phosphorylated SEPT8 are shown. The value 
obtain for wild-type SEPT8 was arbitrary set as 1.0 and the other values were related to this.
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yeast-two hybrid assay and confirmed in mammalian cell 
cultures by coimmunoprecipitation, GST pull-down and 
FRET assays. Moreover, colocalization of  both proteins 
was observed in different cell lines transfected with ex-
pression plasmids for GFP-MK5 and AsRed-SEPT8 fu-
sion. We went on to investigate whether MK5 had kinase 
Figure 4  Mitogen-activated protein kinase-activated protein kinase 5 colocalizes with SEPT8. A: HeLa cells were transfected separately with an expression 
plasmid for GFP-mitogen-activated protein kinase-activated protein kinase 5 (MK5) (left panel) or AsRed-SEPT8 (right panel); B: HeLa cells cotransfected with both 
expression plasmids. The subcellular localization of RFP-tagged SEPT8 (left panel), GFP-tagged MK5 (middle panel), or both proteins (merged; right panel) is shown; C: 
PC12 cells cotransfected with expression vectors for AsRed-SEPT8 (left panel) and GFP-MK5 (middle panel). Colocalization is shown in the right panel; D: Enlarge-
ment of the areas marked by arrows in figures (C) shows clear colocalization of MK5 and SEPT8. After 24 h, cells were fixed and MK5 (green channel) and SEPT8 (red 
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activity towards SEPT8 and it appeared that SEPT8 was 
indeed phosphorylated by MK5 in vitro. To the best of  our 
knowledge, this is the first report linking MAPK-activated 
protein kinases to the group of  septin proteins. However, 
previous studies have identified several mammalian septins 
as substrates of  several kinases. For instance, SEPT1 has 
been shown to be phosphorylated in vitro by aurora-B 
kinase[41]. SEPT2 is a substrate of  casein kinase 2, and its 
phosphorylation on Ser-218 is crucial for the proliferation 
of  hepatoma carcinoma cells[44]. Moreover, SEPT2 is also 
an in vitro substrate for protein kinase (PK)C and cAMP-
dependent PKA[47]. SEPT3 phosphorylation on Ser-91 by 
cGMP-dependent PKG may contribute to the regulation 
of  its subcellular localization in neurons[40]. SEPT5 phos-
phorylation by cyclin-dependent kinase 5 at Ser-17 and 
Ser-327 reduces binding of  septin to syntaxin, therefore 
playing a role in modulating exocytic secretion[42,43]. MK5 
phosphorylates SEPT8 on Ser-271 and with lower stoichi-
ometry on Ser-242 in an in vitro assay. The double SEPT8 
S242A/S271A mutant is still phosphorylated in vitro, 
indicating that other sites may act as MK5 phosphoaccep-
tor sites in vitro. Both sites are conserved in SEPT8 from 
different species ranging from fish to humans (Figure 6). 
This indicates that the sites are crucial for normal func-
tion of  SEPT8. It remains to be tested whether MK5 
can phosphorylate these sites in vivo. Phosphoproteomic 
studies have demonstrated that SEPT8 is phosphorylated 
on Ser-10 and Ser-141 in mouse brain, mouse skin mela-
noma, and nocodazole-arrested HeLa cells[48-50]. Both sites 
are conserved in fish, amphibians, and several mammals 
such as apes, primates, rodents and cattle. The protein 
kinases responsible for these phosphorylations have not 
B
A Synaptophysin AsRed-SEPT8 Merged
10 μm 10 μm
10 μm10 μm10 μm
20 μm 20 μm 20 μm
Synaptophysin MK5 Merged
Figure 5  Mitogen-activated protein kinase-activated protein kinase 5 and SEPT8 colocalize with synaptophysin. A: SK-N-DZ cells were transfected with ex-
pression vector encoding AsRed-SEPT8 and after 24 h, cells were fixed. Synaptophysin was visualized by staining with anti-synaptophysin fluorescein isothiocyanate 
(FITC) conjugate antibody (left panels), while AsRed-SEPT8 was visualized directly (red channel; middle panels). A merged image of red and green channels is shown 
in the right panel; B: SK-N-DZ cells were fixed and stained with anti-synaptophysin FITC conjugate antibody (left panel) and with anti-PRAK antibody followed by Al-
exa Fluor 568 anti-rabbit antibody (middle panel). Merged image of red and green channels is shown in the right panel.
10 μm
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been identified. Our in vitro kinase assay with the peptide 
array did not indicate that Ser-10 and Ser-141 are in vitro 
phosphorylation sites for MK5.
The biological implications of  MK5-mediated phos-
phorylation of  SEPT8 are not known but it may affect 
structural properties by interfering with di- and trimeric 
complex formation with other septins. It has been shown 
for SEPT7 that substitution of  tyrosine-318 into non-
phosphorylatable Ala prevents interaction with SEPT8[30]. 
Phosphorylation of  SEPT8 may have a similar effect on 
complex formation with septins. Phosphorylation may 
also affect the role of  SEPT8 in cellular functions. The 
exact functions of  SEPT8 remain to be elucidated. In ac-
cordance with SEPT5, SEPT8 is implicated in vesicular 
transport and exocytosis processes of  neurotransmitter 
release and platelet secretion. In neurons, SEPT5 binds 
syntaxin, one of  the SNARE proteins, and copurifies with 
synaptic vesicles, suggesting a role in exocytosis and syn-
aptic vesicle dynamics[33,45,51]. Platelets from SEPT5-/- mice 
possess altered serotonin secretion and aggregation[25]. 
SEPT8 expression is high in neurons and platelets, and a 
recent study has suggested the importance of  SEPT8 in 
the process of  SNARE complex formation and subse-
quent neurotransmitter release, but actual experimental 
proof  is lacking[32,34,36,45,52]. Moreover, SEPT8 colocalizes 
with the synaptic marker synaptophysin in primary cul-
tured rat hippocampal neurons[36]. We also observed colo-
calization of  MK5 and synaptophysin in neuroblastoma 
SK-N-DZ cells. MAPK p38, which can act as an upstream 
activator of  MK5[53], has been shown to be involved in 
SNARE-dependent exocytotic release of  brain-derived 
neurotrophic factor from microglia[54]. Finally, transgenic 
mice overexpressing an active variant of  MK5 display dif-
ferent anxiety-related traits as compared to wild-type lit-
termates[5]. All these observations point to a possible role 
of  MK5 in exocytosis that may comprise SEPT8.
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Human (NP_00109228.1) TRIHVCLYFITPTGHSLKSLDLVTMKKLDSKVNIIPIIAKADTISKSELHKFKIKIMGEL
Armadillo (ACQ63032.1) ************************************************************ 
Baboon (NP_001162506.1) ************************************************************
Cattle (AAI20075.1) ************************************************************ 
Chicken (XP_414648.3) *********************************************************S**
Chimpanzee (XP_517927.3) ************************************************************ 
Dog (XP_5319034) ************************************************************ 
Dusky titi (B1MTN8.1) ************************************************************ 




Guinea pig (XP_003464551.1) ************************************************************
Horse (XP_001504480.3) **V*********************************************************




Marmoset (XP_002744650.1) ************************************************************ 
Mouse (CAP19147.1) ************************************************************ 
Naked mole rat (EHB07406.1) *************************************T**********************
Nile tilapia (XP_003447038) ****I*****A**********************************************S**
Opossum (XP_003339562.1) *****************************************************S***S**
Orangutan (XP_002815929.1) ************************************************************
Panda (XP_002913002.1) **V****************************************V**************** 
Pig (XP_003123974.1) ************************************************************ 
Platypus (XP_001510590.2) ************************************************************
Puffer fish (CAG11702.1) ****I*****S************************************************* 
Rabbit (NP_001164820.1) ************************************************************
Rat (NP_001100472.1) ************************************************************ 
Salmon (NP_001167234.1) G*V*I*****A**********************************************S**
Turkey (XP_003210544.1) *********************************************************S** 
Xenopus (NP_001087375.1) S********************************************************S**
Zebra finch (XP_002188929) *********************************************************S**
Zebrafish (NP_001108589) **********S**********************************************S**
Figure 6  Mitogen-activated protein kinase-activated protein kinase 5 phosphoacceptor sites in human SEPT8 are conserved in SEPT8 from other species. 
Alignment of proven and putative SEPT8 proteins in different species of the region encompassing mitogen-activated protein kinase-activated protein kinase 5 phos-
phoacceptor sites Ser-242 and Ser-271 (numbering for human SEPT8). The code in parenthesis refers to the accession number in the Protein database (http://www.
ncbi.nlm.nih.gov/protein/). Asterisk indicates identical amino acid residues. The non-conserved residues are shown in red. The one-letter amino acid code is used. The 
residues corresponding to human SEPT8 Ser-242 and Ser-271 are shown.
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Background
The mitogen-activated protein kinase (MAPK) pathways transmit signals 
through a cascade of phosphorylation events, thereby controlling cellular pro-
cesses such as proliferation, differentiation, migration, survival/apoptosis, and 
gene regulation. The precise function of one of the MAPKs, MAPK-activated 
protein kinase 5 (MK5), remains elusive. The aim of this study was to identify 
new substrates for MK5 in an effort to better understand the function of this 
protein kinase.
Research frontiers
Phosphorylation of proteins at serine, threonine and tyrosine residues by 
protein kinases is an important post-translational modification that controls the 
activity of the substrates. The human genome encodes more than 500 differ-
ent protein kinases, including a large group known as MAPKs. MAPKs control 
through phosphorylation of their substrates crucial cellular processes. Perturbed 
action of these kinases can lead to malignant and nonmalignant diseases. It 
is therefore important to divulge the exact functions and genuine substrates of 
these kinases. This may allow designing therapeutic strategies for pathological 
conditions in which MAPKs play a causal role.
Innovations and breakthroughs
The genuine function of MK5 remains incompletely understood because few 
genuine substrates have been characterized. This study identified septin 8 as 
a novel interaction partner for MK5 and is the first to demonstrate that MAPKs 
can phosphorylate a member of the septin family. Septins are small GTP-
binding proteins that participate in processes ranging from cytoskeletal archi-
tecture, scaffolding, cytokinesis, ciliogenesis, and neurogenesis. The function 
of septin 8 remains enigmatic, but it is enriched at presynapses and interacts 
with several proteins of synaptic vesicles. Hence, septin 8 may be involved in 
neurotransmitter release and the role of septin 8 may be modulated by MK5-
mediated phosphorylation. Interestingly, transgenic mice overexpressing a 
constitutive active variant of MK5 showed changes in anxiety-related behavior.
Applications
Compounds that specifically modify the phosphorylation of septin 8 by modulat-
ing the activity of MK5 or that interfere with the interaction between MK5 and 
septin 8 may have an impact on neuronal secretion and as such be used in 
patients suffering from perturbed neurosecretion.
Peer review
Overall, this is a potentially interesting paper; however, the data presented are 
preliminary.
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